← All stocks

PULSE BIOSCIENCES, INC.

PLSE Net buying

CIK 0001625101 #1646 in the set updated 17 Sep 2026

Bought (12 mo)

$13.50M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$3.72M

$0.00 on a plan · $3.72M straight out of an exercise

Sold at will

$0.00

0 of 11 sales

Net

+$9.78M

+$13.50M against sales at will

By person

8 insiders · 17 transactions

1.0×

Paul A. LaViolette holds only 1.0 times base salary in stock. $749.25K of shares against $708.52K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul A. LaViolette last reported holding, valued at $49.95, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

DUGGAN ROBERT W

Director

$13.00M (1)

—

+$13.00M

48,661,622

68.23%

$2.43B

+14.5%

Danahy Kevin Patrick

Chief Commercial Officer

—

$3.39M (10) scheduled

−$3.39M

43,298

0.0607%

$2.16M

0.0%

UECKER DARRIN

Chief Technology Officer

—

$324.20K (1) scheduled

−$324.20K

284,406

0.3988%

$14.21M

+86.0%

LAVIOLETTE PAUL A

Chief Executive Officer

$295.35K (1)

—

+$295.35K

15,000

0.0210%

$749.25K

—

Teplitsky Liane Rae

Chief Operating Officer

$199.94K (4)

—

+$199.94K

4,095

0.0057%

$204.55K

—

Zanganeh Mahkam

Director

—

725,395

1.02%

$36.23M

+9.1%

Levinson Mitchell E.

Chief Strategy Officer

—

102,401

0.1436%

$5.11M

+5.4%

Barrett Burke Thomas

Former President and CEO

—

63,172

0.0886%

$3.16M

−44.2%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 11

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 331,534

History held since 16 Nov 2016